These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 35236378)

  • 1. Evaluation of neuroprotective and immunomodulatory properties of mesenchymal stem cells in an ex vivo retinal explant model.
    Reboussin É; Buffault J; Brignole-Baudouin F; Réaux-Le Goazigo A; Riancho L; Olmiere C; Sahel JA; Mélik Parsadaniantz S; Baudouin C
    J Neuroinflammation; 2022 Mar; 19(1):63. PubMed ID: 35236378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of Rho kinase inhibitor effects on neuroprotection and neuroinflammation in an ex-vivo retinal explant model.
    Reboussin É; Bastelica P; Benmessabih I; Cordovilla A; Delarasse C; Réaux-Le Goazigo A; Brignole-Baudouin F; Olmière C; Baudouin C; Buffault J; Mélik Parsadaniantz S
    Acta Neuropathol Commun; 2024 Sep; 12(1):150. PubMed ID: 39300576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mesenchymal stem cells provide paracrine neuroprotective resources that delay degeneration of co-cultured organotypic neuroretinal cultures.
    Labrador-Velandia S; Alonso-Alonso ML; Di Lauro S; García-Gutierrez MT; Srivastava GK; Pastor JC; Fernandez-Bueno I
    Exp Eye Res; 2019 Aug; 185():107671. PubMed ID: 31108056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of retinal ganglion cell neuroprotection conferred by platelet-derived growth factor through analysis of the mesenchymal stem cell secretome.
    Johnson TV; DeKorver NW; Levasseur VA; Osborne A; Tassoni A; Lorber B; Heller JP; Villasmil R; Bull ND; Martin KR; Tomarev SI
    Brain; 2014 Feb; 137(Pt 2):503-19. PubMed ID: 24176979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroprotective Effects of Human Mesenchymal Stem Cells and Platelet-Derived Growth Factor on Human Retinal Ganglion Cells.
    Osborne A; Sanderson J; Martin KR
    Stem Cells; 2018 Jan; 36(1):65-78. PubMed ID: 29044808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of the cysteinyl leukotriene pathways increases survival of RGCs and reduces microglial activation in ocular hypertension.
    Trost A; Motloch K; Koller A; Bruckner D; Runge C; Schroedl F; Bogner B; Kaser-Eichberger A; Strohmaier C; Ladek AM; Preishuber-Pfluegl J; Brunner SM; Aigner L; Reitsamer HA
    Exp Eye Res; 2021 Dec; 213():108806. PubMed ID: 34715090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Time-dependent retinal ganglion cell loss, microglial activation and blood-retina-barrier tightness in an acute model of ocular hypertension.
    Trost A; Motloch K; Bruckner D; Schroedl F; Bogner B; Kaser-Eichberger A; Runge C; Strohmaier C; Klein B; Aigner L; Reitsamer HA
    Exp Eye Res; 2015 Jul; 136():59-71. PubMed ID: 26001526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A mouse retinal explant model for use in studying neuroprotection in glaucoma.
    Pattamatta U; McPherson Z; White A
    Exp Eye Res; 2016 Oct; 151():38-44. PubMed ID: 27450912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of an adult rat retinal explant model for screening of potential retinal ganglion cell neuroprotective therapies.
    Bull ND; Johnson TV; Welsapar G; DeKorver NW; Tomarev SI; Martin KR
    Invest Ophthalmol Vis Sci; 2011 May; 52(6):3309-20. PubMed ID: 21345987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paracrine signaling of human mesenchymal stem cell modulates retinal microglia population number and phenotype in vitro.
    Teixeira-Pinheiro LC; Toledo MF; Nascimento-Dos-Santos G; Mendez-Otero R; Mesentier-Louro LA; Santiago MF
    Exp Eye Res; 2020 Nov; 200():108212. PubMed ID: 32910940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Donation of mitochondria by iPSC-derived mesenchymal stem cells protects retinal ganglion cells against mitochondrial complex I defect-induced degeneration.
    Jiang D; Xiong G; Feng H; Zhang Z; Chen P; Yan B; Chen L; Gandhervin K; Ma C; Li C; Han S; Zhang Y; Liao C; Lee TL; Tse HF; Fu QL; Chiu K; Lian Q
    Theranostics; 2019; 9(8):2395-2410. PubMed ID: 31149051
    [No Abstract]   [Full Text] [Related]  

  • 12. Combined treatment of human mesenchymal stem cells and green tea extract on retinal ganglion cell regeneration in rats after optic nerve injury.
    Yang Q; Xu Y; Bin X; Chan KP; Chen S; Qian Z; Yao Y; Yuan XL; Qiu K; Huang Y; Ng TK
    Exp Eye Res; 2024 Feb; 239():109787. PubMed ID: 38211683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extracellular vesicles derived from human ES-MSCs protect retinal ganglion cells and preserve retinal function in a rodent model of optic nerve injury.
    Seyedrazizadeh SZ; Poosti S; Nazari A; Alikhani M; Shekari F; Pakdel F; Shahpasand K; Satarian L; Baharvand H
    Stem Cell Res Ther; 2020 May; 11(1):203. PubMed ID: 32460894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular Mechanisms Mediating Retinal Reactive Gliosis Following Bone Marrow Mesenchymal Stem Cell Transplantation.
    Tassoni A; Gutteridge A; Barber AC; Osborne A; Martin KR
    Stem Cells; 2015 Oct; 33(10):3006-16. PubMed ID: 26175331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroprotective role of sphingolipid rheostat in excitotoxic retinal ganglion cell death.
    Nakamura N; Honjo M; Yamagishi R; Kurano M; Yatomi Y; Watanabe S; Aihara M
    Exp Eye Res; 2021 Jul; 208():108623. PubMed ID: 34022173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transplantation of CX3CL1-expressing mesenchymal stem cells provides neuroprotective and immunomodulatory effects in a rat model of retinal degeneration.
    Huang L; Xu W; Xu G
    Ocul Immunol Inflamm; 2013 Aug; 21(4):276-85. PubMed ID: 23718544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mesenchymal stromal cell-mediated neuroprotection and functional preservation of retinal ganglion cells in a rodent model of glaucoma.
    Mead B; Hill LJ; Blanch RJ; Ward K; Logan A; Berry M; Leadbeater W; Scheven BA
    Cytotherapy; 2016 Apr; 18(4):487-96. PubMed ID: 26897559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroprotection and immunomodulation following intraspinal axotomy of motoneurons by treatment with adult mesenchymal stem cells.
    Spejo AB; Chiarotto GB; Ferreira ADF; Gomes DA; Ferreira RS; Barraviera B; Oliveira ALR
    J Neuroinflammation; 2018 Aug; 15(1):230. PubMed ID: 30107848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Immunomodulatory Potential of Mesenchymal Stem Cells in a Retinal Inflammatory Environment.
    Hermankova B; Kossl J; Bohacova P; Javorkova E; Hajkova M; Krulova M; Zajicova A; Holan V
    Stem Cell Rev Rep; 2019 Dec; 15(6):880-891. PubMed ID: 31863334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroprotective effects of intravitreal mesenchymal stem cell transplantation in experimental glaucoma.
    Johnson TV; Bull ND; Hunt DP; Marina N; Tomarev SI; Martin KR
    Invest Ophthalmol Vis Sci; 2010 Apr; 51(4):2051-9. PubMed ID: 19933193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.